"Chondrolon" is a drug that affects metabolic processes in hyaline cartilage. The specified drug activates the biosynthesis of glucosaminoglycans, and also reduces destructive changes in cartilage tissue. When using the above medicine, pain decreases and the motility of the affected joints improves. It should be noted that the therapeutic effect after using this drug persists for a long time. "Chondrolon" (analogues of this drug are actively used in the treatment of arthropathy, osteoarthrosis, and intervertebral osteochondrosis), doctors often prescribe as part of complex therapy for the treatment of joints. You can use these medicines only with the permission of a doctor. Many experts recommend combining "Chondrolon" (analogues too) with moderate physical activity, which helps to increase blood flow to the joints. The effect of drugs during pregnancy and the lactation period has not yet been sufficiently studied, so the decision for each specific case is made.doctor individually, taking into account all the pros and cons of using the drug. Pharmacies offer analogues of "Chondrolon", the price of which depends on the country of origin.
Analogues of "Chondrolon" on the mechanism of action and therapeutic effect
Pharmaceuticals similar in mechanism of action to Chondrolon include:
- "Chondroitin sodium sulfate";
- "Mukosat";
- "Artradol";
- "Artra chondroitin";
- "Structum";
- "Artrin";
- "Kartilag Vitrum";
- "Chondroxide";
- "Chondroxide" (ointment, gels);
- "Chondrolife";
- "Khonsurid";
- "Chondroguard".
The therapeutic effect of analogues of "Chondrolon" includes the following drugs:
- "Artrovit";
- "Actasulide";
- "Brufen";
- "Burana";
- "Veral";
- "Butadion";
- "Diklobene";
- "Dikloven";
- "Dickloburn";
- "Diclofenac";
- "Long";
- "Donalgin";
- "Dona";
- "Indomethacin";
- "Ibuprofen";
- "Kenalog";
- "Mesulide";
- "Naproxen";
- "Sanaprox";
- "Polcortolon";
- "Ronidase";
- "Nimesil";
- "Ketonal";
- "Sanoprox";
- "Triamsinolone";
- "Flolid";
- "Feloran";
- "Gypsy";
- "Tsefekon" and others.
Issue form
In pharmacies, the drug "Chondrolon" comes in the form of a lyophilisate, packaged in ampoules. One ampoule contains 100 mg of bovine cartilage extract. One package contains ten ampoules complete with a solvent for the preparation of injections and a knife.
Pharmacokinetics of the drug
The most effective medicine "Chondrolon" - injections. After parenteral administration, the drug is rapidly absorbed. Literally half an hour after that, it is found in the blood in low concentrations. Bioactive compounds easily overcome the synovial membrane, so they quickly enter the joint cavity. In the synovial fluid, the bioactive substances of the drug are detected within fifteen minutes after the injection. The treatment course with the use of this drug can be up to 30 injections. If necessary, a repeated therapeutic course is possible.
Means "Chondrolon": analogues and mechanism of their action
Chondroitin sulfate is a mucopolysaccharide that inhibits bone resorption. Optimizes phosphorus-calcium metabolism in cartilage tissue,activates the processes of its regeneration, inhibits degeneration processes in the connective tissue. Stimulates the formation of glycosaminoglycans, increases the synthesis of intra-articular fluid, activates regeneration processes in cartilage tissue. Chondroitin sulfate has a structural similarity to heparin, so it can potentially prevent the formation of blood clots in the subchondria and synovial microvasculature.
Side effects
Side effects may occur when using pharmaceuticals. Most often these are allergic reactions. Sometimes patients using "Chondrolon" (analogues of the drug) may encounter the problem of hemorrhages at the injection sites of the drug. For the same reason, Chondrolon is not recommended for patients with hypersensitivity to the drug, bleeding disorders, a tendency to bleeding, and the presence of thrombophlebitis. Otherwise, the analog of "Chondrolon" in ampoules has established itself as a fairly effective and effective drug. The choice of dosage of the drug depends on the condition of the patient and the type of his disease.
